-
Aarti Drugs Analyst Review 2027: Record Quarter, Profit Up 83% and a P/E Half the Industry’s
- November 17, 2026
- Posted by: Chaitanya Auti
- Category: Market
No Comments
Aarti Drugs posted its highest-ever quarterly revenue, EBITDA and profit in Q2 FY27, with profit up 83% on better API pricing. It still trades at about 20 times earnings. We cover the business, margins, volume gap and 2027 triggers.